Dhanji Rajani | Microbiology | Best Researcher Award

Posted on by ScienceFather

Dr.Dhanji Rajani | Microbiology | Best Researcher Award

Microcare laboratory and Tuberculosis research centre, India

Author Profile

Early Academic Pursuits đź“š

Dr. Rajani’s journey into the world of microbiology began with a strong foundation in science. He completed his B.Sc in Microbiology in 2000 from the prestigious Sir P P Institute of Science. His enthusiasm for laboratory sciences led him to pursue a Postgraduate Diploma in Medical Laboratory Technology (PGDMLT) in 2001 from K K Jani Paramedical Institute.

With a passion for advancing his knowledge, Dr. Rajani completed his M.Sc in Medical Microbiology in 2003 from the Aditya Vikram Birla Postgraduate Institute. His academic rigor culminated in a Ph.D. in Medical Microbiology in 2012 from Bhavnagar University, solidifying his expertise in the field. 🎓

Professional Endeavors 🏥

Dr. Rajani’s career spans nearly two decades, marked by notable contributions to medical microbiology.

  • Microbiologist at Microcare Lab & TRC (2004–Present):
    Dr. Rajani has been a cornerstone of Microcare Lab & TRC, where he continues to lead diagnostic advancements. His role involves overseeing microbiological testing, ensuring accuracy, and implementing innovative diagnostic techniques.
  • Chief Microbiologist at Smt. R B Shah Mahavir Hospital (2009–2013):
    As Chief Microbiologist, Dr. Rajani played a pivotal role in enhancing laboratory operations, managing a team of experts, and ensuring quality assurance in diagnostic services. His leadership contributed to the hospital’s reputation for reliable microbiological testing.

Contributions and Research Focus 🔬

Dr. Rajani’s research interests revolve around medical microbiology, particularly in the diagnosis and management of infectious diseases. His Ph.D. research has added valuable insights to the field, emphasizing innovation in microbial identification techniques.

His work at Microcare Lab involves addressing public health challenges, optimizing diagnostic protocols, and ensuring swift detection of pathogens. Dr. Rajani’s contributions to antimicrobial resistance (AMR) studies are noteworthy, addressing a critical global health concern. 🌍

Accolades and Recognition 🏅

Dr. Rajani’s expertise has earned him recognition among peers and institutions. While leading diagnostic labs, his commitment to quality and precision garnered respect and trust within the medical community.

  • Awards for Excellence: Dr. Rajani has been recognized for his innovative diagnostic methods and dedication to public health.
  • Community Impact: His efforts in ensuring accessible and accurate diagnostics have greatly benefited underprivileged communities, earning him local appreciation.

Impact and Influence 🌟

Dr. Rajani’s career is a testament to the transformative role of microbiology in healthcare. By bridging the gap between research and practical application, he has set benchmarks in laboratory diagnostics. His contributions to training young professionals have been instrumental in fostering the next generation of microbiologists. 👩‍🔬👨‍🔬

His work in microbial testing and infection control has influenced healthcare practices, contributing to improved patient outcomes. Dr. Rajani’s proactive approach to disease surveillance has bolstered public health initiatives.

Legacy and Future Contributions 🌱

Dr. Rajani’s enduring passion for microbiology reflects in his continued efforts at Microcare Lab, where he mentors young scientists and collaborates on groundbreaking projects. His future endeavors aim to:

  • Expand research on emerging infectious diseases and their diagnostic challenges.
  • Advocate for widespread adoption of cost-effective diagnostic tools in resource-limited settings.
  • Promote awareness about antimicrobial stewardship to combat resistance.

His vision is to create a lasting impact on global healthcare through innovation, education, and community service.

Citations

A total of 1,871 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations        1,871
  • h-index          99
  • i10-index       24

Notable Publications 

  • Synthesis of 4-(3-(1-substituted/unsubstituted-phenyl-1H-1,2,3-triazole-4-yl)propoxy)benzaldehydes: In vitro antimicrobial, antimalarial activities and In silico docking study
    • Authors: Al-Salehi, M.A., Parmar, M.P., Rajani, D.P., Patel, H.M., Trivedi, J.H.
    • Journal: Journal of Molecular Structure
    • Year: 2024.
  • Antimycobacterial Activity of Solid Lipid Microparticles Loaded with Ursolic Acid and Oleanolic Acid: In Vitro, In Vivo, and Toxicity Assessments
    • Authors: Saini, V., Mata Espinosa, D., Pandey, A., Hernandez Pando, R., Srivastava, R.
    • Journal: Microorganisms
    • Year: 2024.
  • Design, Synthesis, and Evaluation of Quinoline-1,2,3-Triazole Hybrids as CYP51 Inhibitors: In Silico Study and In Vitro Antimicrobial Assessment
    • Authors: Chabhadiya, B.K., Naik, H.N., Mohite, B.A., Patel, H., Jauhari, S.
    • Journal: ChemistrySelect
    • Year: 2024.
  • Microwave accelerated green access to functionalized pyrazolo[5,1-b]quinazoline-3-carboxylate scaffold and their pharmacological screening
    • Authors: Patel, R.C., Rajani, D.P., Kunjadiya, A., Patel, M.P.
    • Journal: Journal of Molecular Structure
    • Year: 2024.
  • Synthesis, Characterization, Biological Evaluation, and Molecular Docking Study of Novel Isatin Incorporated Thiazolyl Hydrazines
    • Authors: Gore, V.A., Tekale, S.U., Jadhav, M.A., Rajani, D.P., Pawar, R.P.
    • Journal: Letters in Applied NanoBioScience
    • Year: 2024.

Debasmita Mohanty | Microbiology | Best Researcher Award

Posted on by ScienceFather

Ms. Debasmita Mohanty | Microbiology | Best Researcher Award

ICAR-CIFRI, India

Author Profile

Early Academic Pursuits đź“š

Debasmita Mohanty’s academic path in the realm of biotechnology and microbiology started with a strong foundation in science. Her journey began at Sailabala Women’s College in Cuttack, Odisha, where she completed her +2 Science in 2011. She then pursued a Bachelor’s in Microbiology (Honors) from the College of Basic Science and Humanities, Bhubaneswar, Odisha, graduating in 2014 with a solid grounding in microbiology and a score of 66.8%.Her academic pursuits deepened as she joined Utkal University in Bhubaneswar, Odisha, for her Master’s in Applied Microbiology, completing it in 2016 with an impressive 79.4% score. Her master’s thesis explored the beneficial effects of Bacillus subtilis and Clostridium butyricum in Labeo rohita, a species of fish, to combat Aeromonas hydrophila infections. Her work highlighted the importance of beneficial microbes in enhancing fish immunity, a field with significant implications for aquaculture sustainability.In pursuit of advanced knowledge and research, Debasmita embarked on a Ph.D. at Fakir Mohan University, Balasore. Her doctoral research focuses on understanding antimicrobial resistance among Aeromonas spp., with a special emphasis on Extended-Spectrum β-Lactamase (ESBL) resistance in aquatic ecosystems. This critical work aims to address the emerging threats of antimicrobial resistance in water bodies, shedding light on the broader impact of microbial evolution on aquatic life and human health.

Professional Endeavors and Work Experience 🏢

Debasmita began her professional journey in biotechnology and research at ICAR-Central Inland Fisheries Research Institute (CIFRI), Barrackpore. Her initial role as Skilled Supporting Staff in 2018 involved work on the “Determination of e-flow for non-lean and non-monsoon months in respect of Teesta Stage-IV HE Project, Sikkim.” This experience laid the groundwork for her understanding of water resource management and environmental assessments.Following this, she joined a project on “Antimicrobial Resistance in Aquaculture and Fisheries” as Young Professional II at ICAR-CIFRI from May 2018 to November 2023. Her role contributed significantly to understanding the growing issue of antimicrobial resistance in aquaculture, a sector crucial for food security. Her responsibilities included analyzing the impact of antimicrobial agents used in fish farming, investigating microbial resistance patterns, and identifying potential mitigation strategies to combat microbial resistance in aquatic environments.Currently, Debasmita serves as a Project Assistant for the National Mission for Clean Ganga at ICAR-CIFRI. Since November 2024, she has been engaged in research that aims to restore and protect the river Ganga’s ecosystem by focusing on water quality, pollutant reduction, and microbial health. Her work aligns with broader goals of promoting environmental sustainability and conserving aquatic biodiversity, showing her dedication to public welfare and sustainable practices.

Contributions and Research Focus 🌊🧪

Debasmita’s research is centered on combating antimicrobial resistance (AMR) within aquaculture and water ecosystems. Her current focus on ESBL resistance among Aeromonas spp. addresses a serious challenge in the field of environmental microbiology. The findings from her studies contribute to developing guidelines on the responsible use of antimicrobials in aquaculture, aiming to safeguard both human health and ecological balance.Her studies on beneficial microbes’ role in protecting aquaculture species, such as Labeo rohita, highlight her proactive approach toward biosecurity and sustainability. She has contributed valuable insights into microbial therapies as alternative health solutions, reducing the reliance on chemical interventions and fostering healthier ecosystems.

Accolades and Recognition 🏆🌟

Throughout her academic and professional career, Debasmita has demonstrated a commitment to excellence in microbial research and environmental conservation. Her projects with ICAR-CIFRI have not only strengthened her expertise but also positioned her as an advocate for antimicrobial resistance awareness and sustainable practices in aquaculture. Although formal accolades are not detailed, her dedication and impactful work in environmental microbiology and sustainable aquaculture resonate as professional achievements.

Impact and Influence 🌍💧

Debasmita’s work in microbial resistance and sustainable aquaculture resonates with the global push toward environmental sustainability and safe food practices. Her involvement in the National Mission for Clean Ganga aligns with India’s vision for preserving natural resources, especially its critical water bodies. By understanding and mitigating antimicrobial resistance within aquatic ecosystems, Debasmita’s contributions aid in preserving biodiversity and ensuring food safety for future generations.

Legacy and Future Contributions 🔬🌱

Looking ahead, Debasmita Mohanty is likely to continue making strides in environmental biotechnology, with a focus on microbial resistance and sustainable aquaculture practices. Her current research is paving the way for safer aquaculture methodologies, enhanced water management policies, and more effective strategies for combating antimicrobial resistance. She aspires to develop innovative solutions that benefit both ecosystems and communities, bridging the gap between scientific research and practical applications.In summary, Debasmita Mohanty’s journey reflects a dedication to scientific research, environmental conservation, and public welfare. Through her studies, she is shaping a legacy that will inspire future biotechnologists and environmental scientists, contributing to a more sustainable and resilient world. 🌎

Citations

A total of 137 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         137
  • h-index           14
  • i10-index        04

Notable Publications 

  • Prevalence of Extended-Spectrum β-Lactamases (ESBLs) Producing Aeromonas spp. Isolated from Lamellidens marginalis (Lamark, 1819) of Sewage-Fed Wetland: A Phenotypic and Genotypic Approach
    • Authors: Mohanty, D., Das, B.K., Kumari, P., Dasgupta, S., Roy, S.
    • Journal: Microorganisms
    • Year: 2024.
  • Immunomodulatory Effect of Saponin Treatment and Microbial Infections Provoking the Expression of Mx Gene in Catla (Labeo catla)
    • Authors: Panda, S.P., Soren, D., Roy, P., Sahoo, A.K., Das, B.K.
    • Journal: Aquaculture International
    • Year: 2024.
  • Bacillus subtilis and Saccharomyces cerevisiae as Potential Modulators of Hemato-Biochemical Indices, Digestive Enzymes and Disease Resistance in Labeo rohita
    • Authors: Baisakhi, B., Swain, H.S., Bera, A.K., Upadhyay, A., Mohanty, D.
    • Journal: Agricultural Research
    • Year: 2024.
  • Chitosan Extracted from Portunus sanguinolentus (Three-Spot Swimming Crab) Shells: Its Physico-Chemical and Biological Potentials
    • Authors: Pradhan, J., Baisakhi, B., Das, B.K., Ananta, S., Mohanty, D.
    • Journal: Journal of Environmental Biology
    • Year: 2024.
  • Synthesis of Chitosan Nanoparticles from Tasar Silkworm, Antheraea mylitta Pupae and Its Antioxidant Efficacy and Antibacterial Activity Against Fish Pathogens
    • Authors: Baisakhi, B., Mohanty, D., Das, B.K., Jena, K., Pradhan, J.
    • Journal: Journal of Environmental Biology
    • Year: 2023.

Radha Goel | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Dr. Radha Goel | Pharmacology | Best Researcher Award

Lloyd Institute of Management and Technology, Greater Noida, India

Author Profile

🎓 Early Academic Pursuits

Dr. Radha Goel’s academic journey began with a solid foundation in pharmaceutical sciences. She completed her Bachelor of Pharmacy from Hamdard University, New Delhi, in 2002, securing a commendable 67.3%—a significant achievement in a challenging field. Driven by her passion for pharmacology, she further pursued a Master’s degree in Pharmacology at the same university, graduating in 2005 with an impressive 74.8% score. This master’s program provided her with an in-depth understanding of drug interactions, pharmacodynamics, and pharmacokinetics, honing her expertise in pharmacological sciences and setting her on the path to becoming an accomplished researcher and educator.Dr. Goel’s academic journey culminated in a Doctorate in Pharmacology from Jaipur National University in 2012. Her doctoral studies added depth to her research acumen and significantly broadened her knowledge in pharmacology. Additionally, she completed a Post Graduate Diploma in Clinical Research from IGMPI, Gurgaon, in 2016 with a 75.21%, equipping herself with specialized skills crucial for clinical research roles.

👩‍🏫 Professional Endeavors

Dr. Goel’s professional trajectory has been both diverse and impactful, spanning over 17 years in academia and industry. She began her career as a Clinical Research Associate at Jagsonpal Pharmaceuticals Ltd., where she gained hands-on experience in clinical trials and pharmaceutical research from August 2005 to February 2006. This early exposure provided her with practical insights into the industry and set the stage for her transition into academia.In March 2006, Dr. Goel took on her first academic role as a Lecturer at KIET College of Pharmacy, where she remained until August of the same year. Her passion for teaching led her to the Institute of Technology and Science (I.T.S.), Muradnagar, Ghaziabad, where she served in various roles from August 2006 to November 2023. Rising from Lecturer to Assistant Professor, then Associate Professor, and finally Professor, she contributed significantly to the institution’s growth and academic excellence. Currently, she is a Professor at the Lloyd Institute of Management and Technology, Greater Noida, a position she has held since November 11th, 2023, where she continues to inspire the next generation of pharmacologists.

🔬 Contributions and Research Focus

As an educator and researcher, Dr. Goel’s contributions to pharmacology are remarkable. With her background in clinical research and pharmacology, she has focused on areas like drug efficacy, patient safety, and pharmacovigilance, enhancing her students’ understanding of drug interactions, therapeutic protocols, and clinical best practices. Her work as an Animal House In-charge (CCSEA Nominee) is especially noteworthy, as it highlights her commitment to ethical standards in research involving animal subjects, ensuring that all practices comply with regulatory guidelines.Her hands-on approach has allowed her to mentor countless students, guiding them in practical experiments and instilling in them the ethical and technical knowledge required in clinical research. Dr. Goel’s focus on translational research—bridging laboratory findings with clinical applications—continues to influence her teaching, ensuring her students gain real-world insights that enhance their readiness for the pharmaceutical industry.

🏆 Accolades and Recognition

Throughout her career, Dr. Goel has been recognized for her academic and professional achievements. Her expertise in pharmacology and clinical research has made her a sought-after figure in academia, and her appointments to senior roles at various institutions speak to her capabilities and influence. As a CCSEA Nominee and Animal House In-charge, she is acknowledged for her commitment to research ethics and animal welfare in pharmaceutical studies, a role that also reflects her peers’ and students’ respect and trust in her guidance.Dr. Goel’s high performance in her Post Graduate Diploma in Clinical Research from IGMPI and her advanced qualifications in pharmacology have garnered her respect within the academic and research community. Her progression to the role of Professor attests to her dedication, and her continued presence in educational institutions is a testament to her contributions to the field.

🌟 Impact and Influence

Dr. Goel has had a lasting impact on the field of pharmacology, particularly in the Greater Noida and Ghaziabad academic communities. Her deep expertise, combined with a practical approach, has empowered students with knowledge and skills that have helped many succeed in their careers. Her ethical commitment as the Animal House In-charge demonstrates her advocacy for responsible research, influencing a generation of researchers to prioritize ethical standards in their work.Dr. Goel’s influence extends beyond her immediate role as a professor; she has also contributed to academic program development, curriculum enhancement, and the establishment of rigorous academic standards at institutions like I.T.S., Muradnagar, and Lloyd Institute of Management and Technology. Her dedication to fostering a culture of excellence in pharmacology has positively impacted her students, colleagues, and the institutions with which she has been affiliated.

🌍 Legacy and Future Contributions

Looking forward, Dr. Goel’s commitment to pharmacology and clinical research will continue to inspire future healthcare professionals and researchers. Her dedication to educational mentorship, combined with her extensive research experience, positions her to make even greater contributions to the field. As a professor and a leader, she remains a source of guidance and support for her students, helping to mold the future of pharmacology with her knowledge, values, and expertise.In summary, Dr. Radha Goel’s journey from academia to a seasoned professional and dedicated educator stands as a testament to her passion for pharmacology, commitment to ethical research, and her profound influence on students and peers alike. Her story is a reminder of the impact that dedicated educators and researchers can have on their field and the generations to come. 🌱

Citations

A total of 95 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         95
  • h-index           27
  • i10-index        05

Notable Publications 

  • “Nanostructured lipid carriers: Enhancing herbal medicine delivery”
    • Authors: Goel, R., Mishra, R., Singh, N., Singh, R., Gaur, P.K.
    • Journal: Lipid Based Nanocarriers for Drug Delivery, 2024.
  • “Formulation of Phytosomes Containing Rubia cordifolia Extract for Neuropathic Pain: In Vitro and In Vivo Evaluation”
    • Authors: Kumar, N., Goel, R., Ansari, M.N., Puri, D., Singh, M.
    • Journal: ACS Omega, 2024.
  • “Advancing Aluminum-Based Composites with Fly Ash and SiC Reinforcement through Stir Casting”
    • Authors: Abood, A.S., Jisha, P.K., Karuna, G., Goel, R., Chandra, P.K.
    • Journal: E3S Web of Conferences, 2024.
  • “Enhancing Aluminum-Based Composite Manufacturing: Leveraging Si3N4 Reinforcement via Friction Stir Process”
    • Authors: Singh, H., Goel, R., Nagpal, A., Karthiyayini, J., Ahmed, R.
    • Journal: E3S Web of Conferences, 2024.
  • “Nanophytosomal Gel of Heydotis corymbosa (L.) Extract against Psoriasis: Characterisation, In Vitro and In Vivo Biological Activity”
    • Authors: Singh, N., Shaikh, A.M., Gupta, P., Singh, S., Vinayak, C.
    • Journal: Pharmaceuticals, 2024.

Jayshree Annamalai | Microbiology | Best Researcher Award

Posted on by ScienceFather

Dr. Jayshree Annamalai | Microbiology | Best Researcher Award

SRM Institute of Science and Technology, India

Author Profile

Early Academic Pursuits 🎓

Jayshree Annamalai’s academic journey began with a profound interest in the life sciences. She pursued her Bachelor of Science in Microbiology from the prestigious University of Madras in 2008. This foundational course piqued her curiosity about the microbial world, providing her with a deep understanding of microbiological processes and their implications in various industries. Motivated by a desire to delve deeper into the industrial applications of microbiology, she pursued her Master’s degree in Industrial Microbiology from the same university in 2010. During this time, her passion for microbial technology and its role in shaping a healthier environment started to crystallize. To further expand her academic expertise, she completed an M.Phil. in Botany in 2011, also from the University of Madras. This multidisciplinary approach enriched her understanding of both microbial and botanical sciences, setting the stage for her future research endeavors.Her relentless pursuit of knowledge didn’t stop there. Driven by a passion for research, Jayshree embarked on a Ph.D. in Microbiology at Anna University, completing it in 2019. Her doctoral research laid the groundwork for her specialized focus on environmental microbiology, particularly the role of microorganisms in combating environmental pollutants.

Professional Endeavors 🌱

After completing her Ph.D., Jayshree Annamalai began her career as a Postdoctoral Research Fellow at SRM Institute of Science and Technology in Kattankulathur, India. From 2021 to 2024, she dedicated herself to research that explored innovative ways to address some of the pressing environmental challenges of our time, such as plastic degradation and water contamination. Her work primarily focuses on microbial technologies that offer sustainable solutions to these challenges.pOne of the core areas of her postdoctoral research is the myco-degradation of plastics, where she explores the potential of fungi to degrade synthetic polymers, contributing significantly to the fight against plastic pollution. Additionally, she has been involved in the phycological production of biodiesel, which harnesses the potential of algae to produce biofuels, offering a renewable energy source and reducing reliance on fossil fuels. Her work in phyco-synthesis of antioxidant, anticancerous, and antimicrobial agents is another testament to her commitment to using microbial technology to create healthier, more sustainable solutions.Jayshree’s research doesn’t stop at developing green technologies. She has also been at the forefront of exploring the green synthesis of nanoparticles. Her work in creating biogenic, self-assembled nanoparticles has applications in environmental remediation, particularly in the degradation of micropollutants. Moreover, her innovative research on the fabrication of biosensors is geared toward detecting water contaminants with high precision, thus contributing to the availability of clean and safe water.

Contributions and Research Focus 🔬

Jayshree Annamalai’s research interests lie at the intersection of microbial technology and environmental sustainability. Her research has produced a range of significant contributions, particularly in areas such as:

  • Plastic Myco-degradation: Addressing one of the world’s biggest environmental challenges, Jayshree’s work on fungi-mediated plastic degradation presents an eco-friendly solution to the persistent problem of plastic waste.
  • Phycological Production of Biodiesel: By studying the production of biodiesel from algae, she is contributing to the development of renewable energy sources, crucial for reducing carbon emissions and combating climate change.
  • Green Synthesis of Nanoparticles: Jayshree’s innovative work in this field holds promise for the development of new materials that can be used in environmental cleanup processes, especially for the degradation of harmful micropollutants.
  • Biosensors for Water Contaminants: Her research on biosensors has led to the creation of sensitive, biogenic tools for detecting pollutants in water, contributing to global efforts to improve water quality and public health.

Her work stands out due to its interdisciplinary nature, blending microbiology, nanotechnology, and environmental science to address some of the most pressing global challenges. 🌍

Accolades and Recognition 🏅

Throughout her academic and research career, Jayshree Annamalai has received several accolades in recognition of her contributions to the scientific community. Her work has been widely published in leading journals, with numerous citations that highlight the impact of her research on environmental microbiology and green technology. Moreover, her innovative research on the application of biogenic nanoparticles in environmental remediation has garnered attention from both academic and industrial sectors.Her achievements have made her a sought-after speaker at various international conferences, where she has shared her insights on microbial technology and its potential to foster a healthier planet. Through her publications and presentations, she continues to influence researchers and practitioners in the fields of microbiology, nanotechnology, and environmental science. 🌿

Impact and Influence 🌏

Jayshree’s research is not only innovative but also impactful, with the potential to bring about tangible improvements in environmental sustainability. Her work on biogenic self-assembled nanoparticles has paved the way for new technologies that can address water pollution, a critical issue affecting millions globally. The biosensors she has developed are a testament to her ability to translate scientific research into practical applications that can have a real-world impact. Additionally, her work on the myco-degradation of plastics offers hope for reducing plastic pollution, a problem that threatens ecosystems worldwide.Her research contributes to the global movement toward more sustainable industrial practices, cleaner energy sources, and healthier ecosystems, solidifying her reputation as a thought leader in the field of microbial technology. 🌱

Legacy and Future Contributions 🚀

As Jayshree Annamalai continues her research at SRM Institute of Science and Technology, her legacy will undoubtedly be defined by her contributions to environmental sustainability through microbial technology. Looking to the future, Jayshree aims to expand her research on the industrial applications of microbes, focusing on scaling up the biotechnological processes she has pioneered. Her vision is to create a world where microbial technology plays a central role in addressing environmental challenges, from reducing plastic waste to cleaning up water bodies.In the years to come, Jayshree’s work will likely inspire future generations of researchers who seek to harness the power of nature’s smallest organisms to tackle some of the world’s biggest problems. 🌍 Her commitment to sustainability, coupled with her innovative spirit, ensures that her contributions will have a lasting impact on both science and society.

Citations

A total of 823 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         823
  • h-index           23
  • i10-index        11

Notable Publications

  • Title: Nanomaterials in the environment and their pragmatic voyage at various trophic levels in an ecosystem
    Authors: Annamalai, J., Seetharaman, B., Sellamuthu, I.
    Journal: Journal of Environmental Management
    Year: 2024.
  • Title: Green nanomaterials for clean environment: recent advances, challenges, and applications
    Authors: Malairajan, S., Karuvelan, M., Annamalai, J., Chelliah, R., Oh, D.-H.
    Journal: Advances in Smart Nanomaterials and their Applications
    Year: 2023.
  • Title: An integrative review on bioactive compounds from Indian mangroves for future drug discovery
    Authors: Parthiban, A., Sivasankar, R., Sachithanandam, V., Murugan, K., Sridhar, R.
    Journal: South African Journal of Botany
    Year: 2022.
  • Title: Synthesis of various dimensional metal organic frameworks (MOFs) and their hybrid composites for emerging applications – A review
    Authors: Annamalai, J., Murugan, P., Ganapathy, D., Barathi, S., Sundramoorthy, A.K.
    Journal: Chemosphere
    Year: 2022.
  • Title: Electrochemical Sensing of Glucose Using Glucose Oxidase/PEDOT:4-Sulfocalix [4]arene/MXene Composite Modified Electrode
    Authors: Murugan, P., Annamalai, J., Atchudan, R., Reshetilov, A., Sundramoorthy, A.K.
    Journal: Micromachines
    Year: 2022.

PRANJAL GUJARATHI | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Dr. PRANJAL GUJARATHI | Pharmacology | Best Researcher Award

Vidhyadeep Institute of Pharmacy, Vidhyadeep Univeirsty,Surat India

Author Profile

Early Academic Pursuits 🎓📚

Pranjal Gujarathi’s academic journey in pharmacology began with a deep-rooted interest in the sciences. He pursued a focused path in pharmacy and pharmacology, equipping himself with the knowledge necessary to excel in drug research, pharmacodynamics, and pharmacokinetics. His formal education laid the foundation for his future contributions in understanding drug mechanisms and their effects on biological systems. His commitment to academic excellence ensured that he built a strong grounding in pharmacological principles, which later translated into valuable insights in the field of drug discovery and therapeutic innovations.

Professional Endeavors 🧑‍🔬👨‍🏫

Pranjal Gujarathi has had an impactful professional career in pharmacology, spanning teaching and research roles. He began his professional journey as an Assistant Professor of pharmacology at Shree Dhanvantry Pharmacy College in Surat, Gujarat, from July 27, 2017, to May 15, 2021. During his tenure, Pranjal played a pivotal role in mentoring students, designing course curricula, and advancing the department’s research objectives. His teaching covered various aspects of pharmacology, from drug development to therapeutic applications, helping shape the next generation of pharmacists and pharmacologists.In February 2022, Pranjal transitioned into a Junior Research Fellow position at the same institution, a role that allowed him to dive deeper into pharmacological research. His current work focuses on exploring novel drug therapies, pharmacogenomics, and the development of more effective and safer medications. This shift from teaching to dedicated research underscores his versatility and his dedication to pushing the boundaries of pharmacological knowledge.

Contributions and Research Focus 🔬💉

Pranjal Gujarathi’s research has primarily revolved around drug discovery, preclinical studies, and pharmacodynamics, areas where he has made significant contributions. His work emphasizes the understanding of drug-receptor interactions, drug metabolism, and toxicology, all of which are crucial in the early stages of drug development. His role as a Junior Research Fellow allows him to collaborate with other scientists to test the efficacy and safety of new drug formulations before they enter clinical trials.His research is also centered on immunopharmacology and neuropharmacology, focusing on conditions like psoriasis and neurodegenerative diseases. These diseases represent significant challenges in pharmacotherapy, and Pranjal’s preclinical work has helped pave the way for potential breakthroughs in treatment. His expertise in pharmacokinetics, which studies how drugs move through the body, further enhances the precision of his research, allowing for more targeted and effective treatments.

Accolades and Recognition 🏆📜

Pranjal Gujarathi has been widely recognized for his contributions to pharmacology. His research has been published in esteemed journals such as International Immunopharmacology and Naunyn-Schmiedeberg’s Archives of Pharmacology. These publications highlight his growing influence in the scientific community, particularly in the areas of drug discovery in psoriasis and comprehensive studies on Hypericum perforatum in treating neurodegenerative diseases.His academic prowess and ability to translate complex pharmacological concepts into applied research have earned him accolades at conferences and symposia, where his papers have been well-received. These recognitions validate his dedication to advancing the field of pharmacology and underscore his commitment to improving public health through better pharmaceuticals.

Impact and Influence 🌍💊

Pranjal’s influence extends beyond the confines of academia and research. As an educator, he has inspired countless students to pursue careers in pharmacology, instilling in them a rigorous understanding of drug mechanisms and their therapeutic uses. His role in preclinical research has contributed to the development of safer, more effective drugs, influencing the way treatments for chronic diseases like psoriasis are approached.His research on the pharmacological properties of natural products like Hypericum perforatum has opened new avenues in understanding plant-based therapies, potentially offering more accessible and less invasive treatment options for complex conditions. This focus on both synthetic and natural compounds ensures that his work remains relevant across a broad spectrum of pharmacology.

Legacy and Future Contributions 🚀🔝

As Pranjal Gujarathi continues his journey in pharmacological research, his contributions are likely to have a lasting impact on the field. His focus on innovative drug therapies, coupled with his dedication to teaching, positions him as a significant figure in both the academic and scientific communities. His legacy will be defined not only by the drugs developed under his research but also by the knowledge and inspiration he imparts to his students and colleagues.Looking forward, Pranjal is set to make further strides in drug safety evaluations, exploring new territories in personalized medicine and pharmacovigilance. His work has the potential to revolutionize how we understand drug interactions and their effects on different populations, leading to more personalized and effective treatments for patients around the world.

Conclusion 🌟👨‍⚕️

Pranjal Gujarathi’s journey in pharmacology is a testament to his dedication, intellect, and passion for the field. From his early academic pursuits to his significant professional contributions, he continues to influence the development of new drugs and therapies, pushing the boundaries of what’s possible in pharmacological research. With a future that promises even more innovations, Pranjal’s work is sure to leave a lasting legacy in the realm of pharmaceutical sciences.

Notable Publications 

  • Title: Preclinical techniques for drug discovery in psoriasis
    Authors: Gujarathi, P.P., Korat, R.H., Gujarathi, P.S.
    Journal: International Immunopharmacology
    Year: 2024.
  • Title: Hypericum perforatum: A comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative diseases
    Authors: Suryawanshi, M.V., Gujarathi, P.P., Mulla, T., Bagban, I.
    Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology
    Year: 2024.
  • Title: Evaluation of acute intravenous toxicity of HEPES: Is Good’s buffer good and safe enough for clinical utilization in nuclear medicine?
    Authors: Guleria, M., Pallavi, K.J., Gujarathi, P.P., Das, T.
    Journal: Nuclear Medicine and Biology
    Year: 2024.

Nitin Pal Kalia | Microbiology | Best Researcher Award

Posted on by ScienceFather

Dr. Nitin Pal Kalia | Microbiology | Best Researcher Award

National Institute of Pharmaceutical Education and Research Hyderabad- India

Author Profile

🎓Early Academic Pursuits

Nitin Pal Kalia embarked on his academic journey with a focus on biotechnology and clinical microbiology. He completed his M.Sc. in Biotechnology with first-class honors from Guru Nanak Dev University, Amritsar, Punjab, India, in 2006. His passion for research led him to pursue a Ph.D. in the Clinical Microbiology Division at the Indian Institute of Integrative Medicine (IIIM), Jammu, under the guidance of Dr. Inshad Ali Khan. During his doctoral studies (2007-2014), Dr. Kalia made significant contributions to the field, including groundbreaking work on the NorA efflux pump inhibitor capsaicin and its impact on Staphylococcus aureus.

🧑‍🏫Professional Endeavors 

Assistant Professor at NIPER-Hyderabad

Since February 2021, Nitin Pal Kalia has been serving as an Assistant Professor in the Department of Biological Sciences at the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad. His office, Room No. 63, has become a hub for innovative research and academic excellence.

Ramalingaswami Fellow

From August 2019 to February 2021, Dr. Kalia held the prestigious Ramalingaswami Fellowship at CSIR-IIIM, Jammu, India. This fellowship allowed him to further his research in drug discovery and tuberculosis.

Research Fellow at NTU Singapore

Between October 2015 and August 2019, Dr. Kalia was a Research Fellow at the Lee Kong Chian School of Medicine, NTU Singapore. Here, he honed his skills in advanced research methodologies and contributed to significant scientific discoveries.

Visiting Fellow at NIAID-NIH

Dr. Kalia also spent time as a Visiting Fellow at the National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, USA, from May 2014 to July 2015. This experience enriched his research capabilities, particularly in the field of tuberculosis and mycobacteria.

🔬Contributions and Research Focus

Drug Discovery in Tuberculosis

Dr. Kalia’s research has been pivotal in the field of tuberculosis (TB), which remains a major global health challenge. He has focused on discovering new TB drugs and improving the clinical development process for these drugs. His work includes targeting terminal oxidases, specifically the respiratory cytochrome bc1 complex and cytochrome bd-type quinol oxidase, to combat drug-resistant Mycobacterium tuberculosis.

Targeting Cell Wall Synthesis at NIH

During his tenure at NIH, Dr. Kalia evaluated new chemical entities against Mycobacterium tuberculosis mutants. His work aimed to find compounds that target cell wall synthesis, a critical area in TB drug development.

Doctoral Research on Capsaicin

Dr. Kalia’s Ph.D. research revealed capsaicin as an effective inhibitor of the NorA efflux pump in Staphylococcus aureus. His findings demonstrated that capsaicin could significantly reduce the minimum inhibitory concentration of ciprofloxacin and enhance its efficacy, highlighting its potential in overcoming antibiotic resistance.

🏆Accolades and Recognition

Dr. Kalia’s contributions to biomedical research have been recognized through numerous awards and fellowships:

  1. Ramalingaswami Re-entry Fellowship (2017-2018): Awarded by the Department of Biotechnology (DBT), Government of India.
  2. BSL-3 Training: Attended training sessions on biosafety, bio-containment, risk assessment, and management at the National University of Singapore and NIH USA.
  3. IIIM-CSIR Award (2013): Recognized for significant contributions in Discovery Biology, particularly in tuberculosis research.
  4. Indian Council of Medical Research-Senior Research Fellowship: Awarded for his project on evaluating capsaicin and its analogues as multidrug efflux pump inhibitors.

🌍Impact and Influence

Dr. Kalia’s work has had a profound impact on the field of infectious diseases, particularly tuberculosis. His research has paved the way for new drug discoveries and therapeutic strategies. His dedication to teaching and mentoring students at NIPER-Hyderabad has inspired many young minds to pursue careers in biomedical research.

🚀Legacy and Future Contributions

As an Assistant Professor at NIPER-Hyderabad, Dr. Kalia continues to advance the frontiers of biomedical research. His ongoing projects aim to discover new TB drugs and improve existing treatments. Dr. Kalia’s legacy lies in his unwavering commitment to scientific excellence and his ability to inspire future generations of researchers.

Citations

A total of 1513 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations        1513
  • h-index           19
  • i10-index        21

Notable Publications 

  • Title: Antitubercular activity of 2-mercaptobenzothiazole derivatives targeting Mycobacterium tuberculosis type II NADH dehydrogenase
    • Authors: [Authors not provided]
    • Journal: RSC Medicinal Chemistry
    • Year: 2024
  • Title: Cytochrome bd oxidase: an emerging anti-tubercular drug target
    • Authors: [Authors not provided]
    • Journal: RSC Medicinal Chemistry
    • Year: 2024
  • Title: GaMF1.39’s antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876
    • Authors: [Authors not provided]
    • Journal: Microbiology Spectrum
    • Year: 2023-12-12
  • Title: Exploring and exploiting the host cell autophagy during Mycobacterium tuberculosis infection
    • Authors: [Authors not provided]
    • Journal: European Journal of Clinical Microbiology & Infectious Diseases
    • Year: 2023-11
  • Title: Unravelling the flexibility of Mycobacterium tuberculosis: an escape way for the bacilli
    • Authors: [Authors not provided]
    • Journal: Journal of Medical Microbiology
    • Year: 2023-06-01.